Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma, Non-Hodgkin 10Leukemia, Myeloid, Chronic-Phase 10Leukemia, Lymphocytic, Chronic, B-Cell 10Hodgkin Disease 10Multiple Myeloma 9Lymphoma, Mantle-Cell 9Lymphoma, Large-Cell, Immunoblastic 9Lymphoma, Large B-Cell, Diffuse 9Lymphoma, Follicular 9Lymphoma, B-Cell, Marginal Zone 9Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 9Burkitt Lymphoma 9Blast Crisis 9Myeloproliferative Disorders 8Leukemia, Myelomonocytic, Chronic 8Leukemia, Myeloid, Accelerated Phase 8Leukemia, Hairy Cell 8Lymphoma, T-Cell, Cutaneous 7Congenital Abnormalities 7Primary Myelofibrosis 6Breast Neoplasms 6Testicular Neoplasms 5Sezary Syndrome 5Pdgfra-Associated Chronic Eosinophilic Leukemia 5Neoplasms 5Myelodysplastic Syndromes 5Mycosis Fungoides 5Leukemia, Neutrophilic, Chronic 5

Interventions

Thiotepa 3Melphalan 3Cyclophosphamide 3fludarabine phosphate 2fludarabine 2Busulfan 2Alemtuzumab 2Whole-Body Irradiation 1Therapeutics 1Tacrolimus 1Panitumumab 1PLX8394 1Muromonab-CD3 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Immunotherapy 1IFL protocol 1Gemcitabine 1Drug Therapy 1Cetuximab 1Antilymphocyte Serum 1Antibodies 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Histiocytosis × Therapeutics × Myeloid × Clear all
NCT01050439 2015-04-15

Unrelated Donor Transplant for Malignant and Non-Malignant Disorders

Columbia University

Phase 2 Terminated
22 enrolled
LymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Histiocytosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡